BGT vs IMM

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

IMM

IMMUTEP FPO [IMM]

63MEDIUM-HIGH

Score Breakdown

BGT IMM
Technical
48
69
Catalyst
50
71
Sentiment
50
50
Fundamental
44
93
Momentum
52
42
Risk Gate
27
50

Key Metrics

BGT Metric IMM
$6.6MMarket Cap$81.1M
754KAvg Volume (20d)14.6M
N/AShort Interest+2.4%
$0.06152-Week High$0.470
$0.01652-Week Low$0.028
+0.0%Daily Change-1.8%
$0.017Reference Price$0.055
-202.2%ROE-61.8%
N/AProfit MarginN/A

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

IMM Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (6 quarters)
Moderate P/S ratio (10.2x)
Strong revenue growth (+92%)

Ask Scout AI to compare BGT and IMM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs LDX →BGT vs NTI →BGT vs NYR →BGT vs PTX →BGT vs TRU →
BGT Full Analysis → IMM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).